close

Why Dolby Laboratories (DLB) Stock Is Down Today

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

DLB Cover Image

What Happened?

Shares of audio and video technology company Dolby Laboratories (NYSE: DLB) fell 12.5% in the morning session after it reported first-quarter results where a weak forecast for the upcoming second quarter overshadowed a revenue beat. 

Although Dolby's first-quarter revenue grew 7.1% year-over-year to $395.6 million, beating analyst expectations, its GAAP profit of $0.99 per share missed estimates. The main concern for investors, however, was the company's forward-looking guidance. Dolby projected second-quarter revenue of around $310 million, which fell 9.5% short of Wall Street's expectations. 

This cautious sales outlook raised concerns about the company's near-term growth prospects and prompted a negative reaction from the market.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Dolby Laboratories? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Dolby Laboratories’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. Moves this big are rare for Dolby Laboratories and indicate this news significantly impacted the market’s perception of the business.

The biggest move we wrote about over the last year was 2 months ago when the stock dropped 3.3% on the news that investor fears over artificial intelligence disrupting the software industry sparked a broad sell-off. 

The anxiety stemmed from the rapid adoption of new 'agentic AI' tools, which some investors believed could dismantle traditional Software-as-a-Service (SaaS) business models. This 'AI Panic' led to indiscriminate selling across the sector. The market move reflected growing concerns about the downside of the AI boom for established software companies.

Dolby Laboratories is down 11.7% since the beginning of the year, and at $56.07 per share, it is trading 27.9% below its 52-week high of $77.72 from May 2025. Investors who bought $1,000 worth of Dolby Laboratories’s shares 5 years ago would now be looking at only $542.24.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  268.26
+3.20 (1.21%)
AAPL  280.14
+8.79 (3.24%)
AMD  360.54
+6.05 (1.71%)
BAC  53.24
-0.22 (-0.41%)
GOOG  383.22
+1.28 (0.34%)
META  608.75
-3.16 (-0.52%)
MSFT  414.44
+6.66 (1.63%)
NVDA  198.45
-1.12 (-0.56%)
ORCL  171.83
+10.44 (6.47%)
TSLA  390.82
+9.19 (2.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today